Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NFLX vs MRNA✓SelectedUSD · MRNANFLX vs MRNA performance historyLatest closeAs of-2.96%11/20
Stock and ETF performance explorer

NFLX vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-46.3%
MRNA return
+697.5%
Excess return
-743.9%
Maximum drawdown
-48.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-3.0%-2.2%-0.8%-2.9%
7D-8.7%-12.7%+4.0%-8.4%
30D-12.8%-20.7%+7.9%-12.4%
3M-29.2%+46.3%-75.5%-29.9%
6M-35.6%+305.2%-340.8%-37.6%
YTD-39.5%+561.2%-600.7%-38.0%
1Y-46.3%+772.1%-818.4%-40.9%
All-46.3%+697.5%-743.9%-40.9%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling